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SUMMARY
 
Aspergillus fumigatus
 
 (
 
Afu
 
) is an important fungal pathogen causing allergic and invasive respiratory
disorders. A plethora of multi-functional allergens/antigens secreted by 
 
Afu
 
 have been implicated in
pathogenesis. The present study was undertaken to identify and characterize novel 
 
Afu
 
 allergen/antigen
by cDNA library approach. cDNA library of 
 
Afu
 
 was immunoscreened with pooled sera of allergic
bronchopulmonary aspergillosis (ABPA) patients. The cDNA clone, TS1, reacting significantly with
specific IgG antibodies, was selected. cDNA was subcloned and expressed in 
 
Escherichia coli.
 
 Sequenc-
ing of the cDNA revealed an open reading frame (ORF) of 1179 bases coding for a protein with an
approximate molecular weight of 44 kDa. Immunoreactivity of the recombinant TS1 protein (rTS1) was
evaluated by ELISA and Western blot analysis using pooled sera of ABPA patients. The rTS1 exhibited
binding to specific IgG and IgE antibodies present in sera of ABPA patients. The deduced amino acid
sequence showed homology to 60S ribosomal protein L3 (RpL3) of 
 
Aspergillus nidulans
 
, 
 
Saccharomy-
ces cerevisiae
 
 and 
 
Homo sapiens
 
. The RpL3 of 
 
S. cerevesiae, tcm1
 
, to which TS1 sequence shows signif-
icant homology (72% identity), is known to be responsible for conferring resistance against
trichodermin (antibiotic, inhibiting protein synthesis). The present study has led to identification, clon-
ing and expression of a 44-kDa novel allergen/antigen of 
 
Afu
 
 with sequence homology to L3 ribosomal
protein with a probable role in resistance of 
 
Afu
 
 to antifungal drugs. Sixty-four per cent sequence iden-
tity of 
 
Afu
 
 RpL3 with human RpL3 and common regions in their predicted epitopes suggest a possibility
of involvement of 
 
Afu
 
 RpL3 in autoimmune reactions due to molecular mimicry.
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INTRODUCTION
 
Aspergillus fumigatus
 
 (
 
Afu
 
), a ubiquitous mould, is an opportu-
nistic pathogen associated with allergic and invasive aspergillosis
[1]. This pathogenic fungus secretes several virulence factors
which facilitate crossing of epithelial barriers, leading to disease
development [2]. A number of multi-functional allergens/antigens
secreted by 
 
Afu
 
 also contribute to pathogenicity [3].
Elevated serum levels of IgG and IgE antibodies against aller-
gens/antigens of 
 
Afu
 
 are used as an important diagnostic criteria
in 
 
Afu
 
-induced allergic disorders [4]. A major problem in the
diagnosis of 
 
Afu
 
-induced allergic disorders arises from the lack of
standardized diagnostic reagents. Commercial 
 
Afu
 
 extracts show
variable allergenicity owing to the differences in the strain used,
growth conditions, harvesting and extraction procedures [5].
Although the extracts of 
 
Afu
 
 are known to contain approximately
200 different proteins, glycoproteins and low molecular weight
compounds, the current update of 
 
Afu
 
 allergens by the Interna-
tional Union of Immunological Societies (WHO/IUIS, http://
www.allergen.org/List.html) lists only 19 allergens from 
 
Afu
 
 [6].
Introduction of the molecular biology approaches such as the
cDNA library has allowed cloning, characterization and produc-
tion of large amounts of single and highly pure 
 
Afu
 
 allergens in a
rapid manner [7,8]. Screening of cDNA libraries with patient
sera leads to identification of several previously undescribed
allergens in virtually a single experiment. Positive clones are
sequenced and compared to known sequences in the electronic
databank. Identification and characterization of various aller-
gens/antigens of 
 
Afu
 
 would contribute substantially to under-
standing of pathogenesis and biology of the fungus. Such studies
would also facilitate development of novel effective therapeutic
strategies, in view of the serious limitations of the currently
available antifungal therapies, such as toxicity and development
of drug-resistant strains.
The present study describes the molecular cloning and expres-
sion of a novel 44-kDa immunoreactive protein from the 
 
Afu
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cDNA library. The deduced amino acid sequence of the cDNA
shows homology with L3 ribosomal protein (RpL3), a component
of 60S ribosomal subunit, from different organisms, including 
 
H.
sapiens
 
. This protein is an important component of peptidyl trans-
ferase centre of the ribosome and has also been involved in con-
ferring resistance to protein synthesis inhibiting drugs such as
trichodermin in 
 
S. cerevisiae
 
.
 
MATERIALS AND METHODS
 
Materials
 
Serum samples of allergic bronchopulmonary aspergillosis
(ABPA) patients (
 
n
 
 
 
=
 
 30) (following Rosenberg’s criteria) and
normal subjects (
 
n
 
 
 
=
 
 10) were obtained from Vallabhbhai Patel
Chest Institute, Delhi as per the guidelines of the institutional
human ethics committee [9]. The parameters taken into
account for the selection ABPA patients are: asthma, periph-
eral blood eosinophilia (
 
>
 
1·0 
 
¥
 
 10
 
9
 
/l), immediate cutaneous
reactivity to 
 
Afu
 
 antigen, precipitating antibodies against 
 
Afu
 
antigen, elevated total serum IgE (
 
>
 
1000 ng/ml), chest X-ray
infiltrates (or history of), transient or fixed proximal bron-
chiectasis, elevated serum IgE and IgG antibodies (specific to
 
Afu
 
 antigen).
Restriction enzymes and ligase were purchased from New
England Biolabs (Beverley, MA, USA). Polymerase chain reac-
tion (PCR) was performed using the thermal cycler from Perkin
Elmer Cetus. DNA amplification reagents were purchased from
Bangalore Genei (Bangalore, India). GFX
 
TM
 
 DNA and gel band
purification kit for purification of PCR products was obtained
from Amersham Pharmacia Biotech Inc. (Piscataway, NJ, USA).
Nitrocellulose membranes were purchased from Schleicher and
Schuell (Keene, NH, USA). Peroxidase conjugated antihuman
IgG and antihuman IgE antibodies were obtained from Sigma (St
Louis, MO, USA).
 
cDNA library
Afu
 
 cDNA library constructed in Uni-ZAP XR lambda vector
was obtained from Stratagene (La Jolla, CA, USA). 
 
Escherichia
coli
 
 strains XL-1 Blue MRF
 
¢
 
 and SOLR (Stratagene, La Jolla,
CA,  USA)  were  used  for  recombinant  DNA  manipulations.
The cDNA library was amplified using the manufacturer’s
instructions.
 
Antibody screening of cDNA library and selection of clone
 
Immunoscreening of a 
 
l
 
ZAP cDNA library was performed under
standard conditions [10]. Briefly, 
 
E. coli
 
 XL-1 blue were infected
with 6 
 
¥
 
 10
 
8
 
 phages containing cDNAs and plated onto NZY-agar
plates. Expression of fusion protein was induced by overlapping
nitrocellulose filters impregnated with 10 m
 
M
 
 isopropyl-beta-D-
thiogalactopyranoside (IPTG) and followed by incubation of the
plates for 4 h at 42
 
∞
 
C. The plates were incubated further at 37
 
∞
 
C
for another 4 h. Filters were washed first with Tris-buffer saline
(TBS) (10 m
 
M
 
 Tris, pH 8·0, 150 m
 
M
 
 NaCl, TBS) with 0·05% v/v
Tween 20. They were then blocked with 3% skimmed milk pow-
der in TBS at 37
 
∞
 
C for 1 h and were incubated overnight with
pooled sera of ABPA patients (
 
n
 
 
 
=
 
 10) (preabsorbed against 
 
E.
coli
 
 proteins and diluted 1 : 100 in TBS). Filters were washed in
TBS containing 0·05% (v/v) Tween 20 (TBST), and reacted with
HRP conjugated antihuman IgG (diluted 1 : 1000 in TBS). Mem-
branes were given a final wash in TBST and were developed with
3,3
 
¢
 
 diaminobenzidine tetrahydrochloride and 0·3% v/v hydrogen
peroxide. TS1 was one of the positive clones. Selected plaque was
rescreened, purified to homogeneity and corresponding pBlue-
script SK (
 
+
 
/–) phagemid was rescued by 
 
in vivo
 
 excision using
ExAssist helper phage. The 
 
E. coli
 
 SOLR cells were infected with
the phagemid and were plated onto LB-ampicillin (50 
 
m
 
g/ml) agar
plates and incubated at 37
 
∞
 
C overnight. Colonies appearing on
the plate containing the pBluescript double-stranded phagemid
having the cloned DNA insert was used for colony PCR using T3
(5
 
¢
 
AAT TAA CCC TCA CTA AAG GG-3
 
¢
 
) and T7 (5
 
¢
 
CGG GAT
ATC ACT CAG CAT AAT G-3
 
¢
 
) primers. PCR cycling conditions
were 94
 
∞
 
C/4
 
¢
 
 and 28 cycles of 94
 
∞
 
C/1
 
¢
 
, 58
 
∞
 
C/1·5
 
¢
 
, 72
 
∞
 
C/2
 
¢
 
 followed
by a terminal extension cycle at 72
 
∞
 
C/7
 
¢
 
.
 
Sequence analysis of TS1
 
The PCR product thus obtained was sequenced using T3, T7 and
two internal primers, Int 1 (5
 
¢
 
-GAC AGT ATC TTC GAG AAG
GAC GA-3
 
¢
 
) and Int 2 (5
 
¢
 
-CGC AAC CTG TTC GAG AAG
CCC ATT-3
 
¢
 
). Automated DNA sequencing and oligonucleotide
synthesis was performed by sequencing facility at the Institute of
Genomics and Integrative Biology, using ABI-3100 DNA
sequencer (Applied Biosystems). The deduced amino acid
sequence was determined using the Translate Tool software in the
Expasy Molecular Biology Server (http://www.expasy.com). The
deduced amino acid sequence was submitted to the database of
National Center for Biotechnology Information (NCBI) using the
Basic Local Alignment Search Tool (
 
BLAST
 
) server for nucleotide
and amino acid homology searches (http://www.ncbi.nlm.nih.gov/
BLAST).
 
Subcloning, expression and purification of rTS1
 
The cDNA insert was amplified using the modified forward
primer (5
 
¢
 
-AGC GAC AAC AGG AAT TCG ATG AGT CAC
CGG AAG TAC-3
 
¢
 
, carrying an 
 
Eco
 
RI site) and T7 as reverse
primer. The amplified product was digested with 
 
Eco
 
RI and
 
Xho
 
I, and the resulting fragment was inserted into pGEX-5X-3
expression vector, which was digested previously with the same
restriction enzymes. The resulting plasmid was designated as
pGEX-TS1. 
 
E. coli
 
 strain BL21 was transformed with plasmid
pGEX-TS1 following the standard method [11]. The trans-
formed cells were grown in 2 YT medium containing 100 
 
m
 
g/ml
ampicillin at 37
 
∞
 
C until the OD
 
600
 
 reached 0·5. IPTG was then
added to a final concentration of 0·5 m
 
M
 
, and the culture was
grown for an additional 5 h at 37
 
∞
 
C with shaking. Cells were
harvested by centrifugation at 5000 
 
g
 
 for 15 min and resus-
pended in 20 ml sonication buffer (50 m
 
M
 
 Tris/HCl pH 7·4,
150 m
 
M
 
 NaCl, 1 m
 
M
 
 EDTA, 10% (v/v) glycerol, 1 m
 
M
 
 PMSF
and 10 
 
m
 
g/ml aprotinin). The cells were sonicated on ice for
2 min, and sonicate was supplemented with Triton X-100 to a
final concentration of 1% before centrifugation at 30 000 
 
g
 
 for
30 min at 4
 
∞
 
C. The supernatant was incubated overnight at 4
 
∞
 
C
with glutathione–Sepharose 4B matrix (Pharmacia Biotech).
The resin bound to protein was packed into a column and
washed with five bed volumes of phosphate-buffered saline
(PBS) (1·44 g disodium hydrogen phosphate, 0·24 g potassium
dihydrogen orthophosphate, 0·2 g potassium chloride, 8·0 g
sodium chloride in 1 l distilled water, pH 7·2, PBS). Protein
was eluted with 50 m
 
M
 
 Tris/HCl pH 8·0 containing 1 m
 
M
 
 1,4-
dithiothreitol (DTT), 5 m
 
M
 
 MgCl
 
2
 
 and 15 m
 
M
 
 glutathione.
Fractions containing purified rTS1 protein were pooled and the
purity  of  the  recombinant  protein  was  confirmed  on  10%
SDS-PAGE.
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Immunoblotting of recombinant protein with pooled sera of 
ABPA patients
 
For immunoblot analysis, rTS1 was separated by 10% SDS-PAGE
and transferred to nitrocellulose membrane at constant current of
100 mA for 4 h in Bio-Rad mini Trans-blot cell. The nitrocellulose
membrane was blocked with 3% non-fat milk in PBS at 37
 
∞
 
C for
1 h followed by washing. The membrane strips were incubated at
4
 
∞
 
C overnight with 1 : 100 v/v dilution (for IgG) or 1 : 50 dilution
v/v (for IgE) of pooled sera of ABPA patients and pooled sera of
controls. After overnight incubation, the strips were washed and
treated with peroxidase-conjugated antihuman IgG (1 : 1000 v/v)
and antihuman IgE (1 : 1000 v/v) antibodies for 1 h at 37
 
∞
 
C. The
membrane was washed further and incubated with substrate, 3,3
 
¢
 
diaminobenzidine tetrahydrochloride and 0·3% v/v hydrogen per-
oxide. The enzyme reaction was stopped by rinsing with deionized
water.
 
Specific IgG and IgE binding of TS1 fusion protein by 
indirect ELISA
An indirect ELISA [12] was used to screen the pooled sera of
ABPA patients and pooled sera of controls (1 : 100 v/v for IgG
and 1 : 50 v/v for IgE) for the presence of serum antibodies spe-
cific to rTS1.
Immunodot-blot
The allergenicity of rTS1 was determined in vitro by dot-blot
immunoassay using a panel of sera from 30 ABPA patients fol-
lowing standard protocol [13]. Briefly, 1 mg of rTS1 fusion protein
was applied onto Hybond C nitrocellulose membrane (Amer-
sham Life sciences, UK). Five mg of Afu 3-week culture filtrate (3
wcf) was used as positive control while 1 mg of purified
glutathione-S-transferase (GST) was used as a negative control
(because culture filtrate is a mixture of number of allergens/anti-
gens, five times more quantity was used than the purified pro-
teins). Dot blots were blocked with 5% non-fat milk powder in
PBST (PBS with 0·05% Tween 20). The blots were incubated sep-
arately with 1 : 50 (v/v) dilution of sera of 30 ABPA patients for 3
h at 37∞C. After three washes with PBST, the blots were incubated
with peroxidase conjugated antihuman IgE (1 : 1000 v/v) for 1 h at
37∞C. A similar washing procedure was followed and the blots
were developed with substrate, 3,3¢ diaminobenzidine tetrahydro-
chloride and 0·3% v/v hydrogen peroxide. All reactions with vis-
ible dots (compared to positive control dots) were scored as
positive. The enzyme reaction was stopped by rinsing with deion-
ized water.
Identification of epitopic regions
The DNASTAR module of the Lasergene software package was
used for computational analysis of deduced amino acid sequence.
Various algorithmic programs were used, such as the Chou–Fas-
man algorithm (prediction of secondary structure), the Hopp–
Woods method (protein antigenic determinants), the Kyte and
Doolittle method (regional hydropathy of protein) and Jameson
Wolf’s method for antigen index and identification of probable
epitopic regions [14].
RESULTS
PCR and sequence analysis of the cDNA clone, TS1
Sequencing of the cDNA insert using T3, T7, Int1 and Int2
revealed an ORF of 1179 base pairs coding for 392 amino acids.
The cDNA has a complete 3¢ untranslated region with a poly A
tail. A polyadenylation signal, AATAAA, was present 18 base
pairs  upstream  of  the  poly  A  tail.  The  sequence  of  TS1  cDNA
was submitted to the NCBI GenBank (Accession number:
BankIt439468, AF464911).
BLASTX homology search results showed that the deduced
amino acid sequence shares significant homology with L3 riboso-
mal proteins of different organisms (Fig. 1). It showed 91% iden-
tity with Emericella nidulans (A. nidulans), 72% with S. cerevisiae,
71% with Schizosaccharomyces pombe and 64% with H. sapiens.
The sequence analysis of TS1 revealed that a ribosomal
protein L3 signature ([FL]·{6}[DN]·{[2} [AGS]·[ST]·
G[KRH]G·{2}G·{3{R) was present at residue 210–233. Four
nuclear localization signals were present in the sequence (PRKR
at position 18, PRKRAAR at 18, PLKQKKA at 171, PGVKKRV
at 330). In addition to this, one potential glycosylation site at posi-
tion 294–297 (N[^P][ST][^P] motif) and four potential myristoy-
lation sites at positions 142, 186, 289 and 327
(G[^EDRKHPFYW]·{2}[STAGCN][^P] motif) were also
present (Fig. 1).
Characterization of purified rTS1
The purified rTS1, expressed as GST fusion protein, resulted in a
single band on denaturing 10% SDS-PAGE (Fig. 2 a). The pre-
dicted size of GST-TS1 was 73 kDa (44 kDa for TS1 protein and
29 kDa for the attached GST protein).
Immunoreactivity of rTS1
rTS1 showed reactivity with IgE and IgG antibodies in the pooled
sera of ABPA patients on Western blot (Fig. 2b). The ELISA
absorbance value of rTS1-specific IgG antibodies in pooled sera
of ABPA patients was 5 fold higher than the controls (Table 1).
The ELISA absorbance value of rTS1-specific IgE antibodies in
pooled sera of ABPA patients was 6·4-fold higher than the con-
trols (Table 1). In the dot-blot analysis, seven of 30 ABPA patients
(26·7%) showed presence of IgE antibodies against rTS1 (Fig. 3).
All the 30 sera showed presence of specific IgE antibodies against
3 wcf of Afu. Because rTS1 was expressed as a fusion protein with
GST, purified GST alone was used as a negative control to rule
out non-specific reaction of ABPA sera with GST. None of the 30
sera reacted with GST.
Prediction of antigenic index and epitopic analysis
The deduced amino acid sequence of TS1 was analysed for the
prediction of potential antigenic determinants by using the PRO-
TEAN module of LASERGENE. This analysis predicted several
potential antigenic sites and 11 regions were observed to have a
high antigenic index (Table 2).
Table 1. The indirect ELISA optical density values of rTS1-specific IgG 
and IgE antibodies
Serum samples used
Absorbance values
IgG IgE
Pooled ABPA patients sera 0·624 ± 0·050 0·256 ± 0·021
Normal human sera 0·124 ± 0·054 0·040 ± 0·034
All the readings are mean values representing three readings for each 
sample.
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Fig. 1. Multiple sequence alignment of the amino acid sequences of L3 ribosomal protein from Aspergillus fumigatus, A. nidulans,
Saccharomyces cerevisiae and Homo sapiens. The sequences have been aligned with CLUSTAL W (DNASTAR). The amino acid residues that
differ from the consensus are shaded. The result indicates a high degree of homology among the various L3 ribosomal proteins from
different organisms. The L3 signature is underlined. The boxed amino acid sequences represent the nuclear localization signals. The potential
N-glycosylation site is underlined with a double line.
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DISCUSSION
The current study, involving immunoscreening of the cDNA
library of Afu, led to identification and expression of a 44-kDa
protein with sequence homology to L3 ribosomal proteins.
Significantly higher levels of specific IgG and IgE antibodies to
the purified protein observed in sera of ABPA patients than con-
trols suggested that it may be a novel allergen/antigen of Afu.
Although other ribosomal proteins such as P2, L7 and L12 have
been found to be allergenic/antigenic in Afu, Cladosporium her-
barum and Brucella melitensis, none of the RpL3s has been pro-
posed as an allergen/antigen until now [15–17]. The presence of
IgE antibodies to rTS1 in 26·7% of the ABPA patients indicated
that it may be a minor allergen of Afu according to the allergen
nomenclature guidelines given by the IUIS (IUIS, allergen
nomenclature subcommittee, http://www.allergen.org/Editoral.
html).
Multiple sequence alignment using the sequences of RpL3
from Afu, A. nidulans, S. cerevisiae and H. sapiens showed that
this protein belongs to the category of highly conserved proteins.
RpL3 is vital for the function of the ribosome and has been
shown to participate in or initiate the early steps of the riboso-
mal assembly, where it binds with high affinity to the 23S rRNA
[18,19]. It is involved in the formation of the peptidyltransferase
centre and is essential for its catalytic activity [20–23]. The L3-
binding site has been localized to a long double helix, containing
a large internal loop and a sarcin/ricin loop in domain VI of 23S
rRNA [24,25].
The deduced amino acid sequence showed significant
homology to tcm1, which encodes RpL3 of S. cerevisiae. It is
interesting to note that tcm1 has been implicated in resistance
of S. cerevisiae to trichodermin (an inhibitor of ribosome pepti-
dyl transferase activity) [26,27]. Although many strains of Afu
have been shown to be resistant to antibiotics, only limited
information is yet available regarding the genes conferring anti-
biotic resistance to Afu. However, recently Afu ribosomal stalk
proteins such as P0 phosphoprotein has been implicated in
resistance to sordarin antifungals [28]. On the basis of signifi-
cant sequence homology to tcm1, the RpL3 of Afu could be
implicated in antibiotic resistance of Afu, although this requires
experimental confirmation.
Fig. 2. (a) 10% SDS-PAGE stained with Coomassie blue R-250 showing
expression and purification of rTS1 fusion protein from a cDNA clone.
Lane M, molecular weight marker in kDa; lane 1, uninduced E. coli cell
lysate; lane 2, induced Escherichia coli cell lysate (IPTG-induced expres-
sion of rTS1 fusion protein from E. coli cells); lane 3, purified rTS1 fusion
protein (~73 kDa). (b) Specific IgG and specific IgE binding of rTS1. The
recombinant protein was resolved on 10% SDS-PAGE and electroblotted
onto nitrocellulose membrane at 50 mA overnight 4∞C. The blots were
probed with pooled sera of ABPA patients and pooled sera of controls.
Lane 1, IgG/sera of controls (1 : 100); lane 2, IgG/sera of ABPA patients
(1 : 100); lane 3, IgE/sera of controls (1 : 50); lane 4, IgE/sera of ABPA
patients (1 : 50).
M 1 2 3
97
66
43
20
14
(a)
1 2 3 4
(b)
Fig. 3. Allergenicity of rTS1 by dot-blot immunoassay. Ten representative
panels of the IgE dot-blot immunoassay are shown. Purified rTS1 and GST
were used at 3 mg/dot and 3 wcf was used at 6 mg/dot.
1 2 3 4 5 6 7 8 9 10
GST
rTS1
3wcf
Table 2. The amino acid sequences of epitope regions of rTS1
Number
Predicted epitopic regions
Amino acid
positions Amino acid sequence
1 1–14 MSHRKYEAPRHGSL
2 17–43 LPRKRAARHRGKVKSFPKYDPKKPVHL
3 56–75 VVRDLDRPGAKMHKKEIVEA
4 94–103 ETPRGLRSLT
5 109–130 HLSDEVKRRFYKNWYKSKKKAF
6 133–158 YAKKHAEENGASITRELERIKKYCTV
7 166–180 QIRKTPLKQKKAHLM
8 231–250 TSRWGTKKLPRKTHKGLRKV
9 274–285 HHRTSCNHKVFR
10 286–309 IGKGSDEGNASTDFDISKKQITPM
11 343–370 LYPQTSRRATEKVELKWIDTSSKFGHGA
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Sixty-four per cent sequence identity of Afu RpL3 with
human RpL3 and common regions in their predicted epitopes
suggests the possibility of involvement of Afu RpL3 in autoim-
mune reactions. There are reports of the involvement of phyloge-
netically conserved proteins of Afu in autoimmune reactions in
patients of aspergillosis, such as Asp f6 (manganese superoxide
dismutase), Asp f8 (P2 acidic ribosomal protein) and Asp f11
(cyclophilin) (sequence identity of >50% with the corresponding
human protein) [15,29,30]. In a previous study, significantly high
levels of specific IgG and IgE antibodies to human fibronectin and
collagen type IV were observed in sera of ABPA patients,
suggesting the role of autoimmune reactions in immunopathogen-
esis of aspergillosis [3]. Tissue damage due to the inflammatory
process observed in patients of aspergillosis might result in
release of autoantigens [31]. Exposure to autoantigens containing
cross-reactive determinants (molecular mimicry) can result in an
autoimmune response by recruiting the memory T cell repertoire
at the site of inflammation.
In conclusion, the present study has led to identification of a
novel allergen/antigen of Afu with sequence homology to L3
ribosomal protein, which may be involved in autoimmune reac-
tions in patients of aspergillosis and in conferring drug resis-
tance to Afu.
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